Bir Dawn Carter

Officer at REATA PHARMACEUTICALS INC

Sold, on record
$26.1M
Dollars the filings state
Form 4 sales
7
Latest Aug 16, 2023
Form 144 notices
6
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice REATA PHARMACEUTICALS INCNotice
    May 16, 2023 2023

    Filed to sell 417 shares ($34k)

    Bir Dawn Carter, Officer

    No 10b5-1 plan0x usual sizeFiling

  2. 2 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    May 16, 2023 same day

    Sold 1,311 shares at $83.78 ($110k)

    Bir Dawn Carter, Chief Commercial Officer

    No 10b5-1 planSold 4.1% of holdings ($2.7M position)30,885 shares left0.1x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Jul 28, 2023 +73 days

    Filed to sell 20,000 shares ($3.3M)

    Bir Dawn Carter, Officer

    10b5-1 plan3.5x usual sizeFiling

  4. 4 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Jul 28, 2023 same day

    Filed to sell 20,000 shares ($3.3M)

    Bir Dawn Carter, Officer

    10b5-1 plan3.5x usual sizeFiling

  5. 5 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Jul 28, 2023 same day

    Sold 40,000 shares at $164.54 ($6.6M)

    Bir Dawn Carter, Chief Commercial Officer

    10b5-1 planSold 53.3% of holdings ($12.3M position)35,010 shares left7x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Aug 15, 2023 +18 days

    Filed to sell 807 shares ($136k)

    Bir Dawn Carter, Officer

    No 10b5-1 plan0.1x usual sizeFiling

  7. 7 Form 144 notice REATA PHARMACEUTICALS INCNotice
    Aug 16, 2023 +1 day

    Filed to sell 398 shares ($67k)

    Bir Dawn Carter, Officer

    No 10b5-1 plan0x usual sizeFiling

  8. 8 Form 4 sale REATA PHARMACEUTICALS INCNo plan
    Aug 16, 2023 same day

    Sold 1,205 shares at $168.81 ($203k)

    Bir Dawn Carter, Chief Commercial Officer

    No 10b5-1 planSold 3.4% of holdings ($5.9M position)33,805 shares left0.1x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Bir Dawn Carter
Source
Aug 16, 2023Aug 17, 2023REATA PHARMACEUTICALS INCChief Commercial OfficerForm 4 sale1,205$203k3.4%No planSEC
Aug 16, 2023Aug 16, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice398$67kNoticeSEC
Aug 15, 2023Aug 15, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice807$136kNoticeSEC
Jul 28, 2023Aug 1, 2023REATA PHARMACEUTICALS INCChief Commercial OfficerForm 4 sale40,000$6.6M53.3%UnusualSEC
Jul 28, 2023Jul 28, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice20,000$3.3MNoticeSEC
Jul 28, 2023Jul 28, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice20,000$3.3MNoticeSEC
May 16, 2023May 17, 2023REATA PHARMACEUTICALS INCChief Commercial OfficerForm 4 sale1,311$110k4.1%No planSEC
May 16, 2023May 16, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice417$34kNoticeSEC
May 15, 2023May 15, 2023REATA PHARMACEUTICALS INCOfficerForm 144 notice894$76kNoticeSEC
Mar 13, 2023Mar 15, 2023REATA PHARMACEUTICALS INCChief Commercial OfficerForm 4 sale9,317$808k22.4%Plan not statedSEC
Mar 7, 2023Mar 8, 2023REATA PHARMACEUTICALS INCChief Commercial OfficerForm 4 sale96,996$8.5M70.0%UnusualSEC
Mar 3, 2023Mar 6, 2023REATA PHARMACEUTICALS INCChief Commercial OfficerForm 4 sale2,166$191k4.3%Plan not statedSEC
Nov 9, 2020Nov 10, 2020REATA PHARMACEUTICALS INCChief Commercial OfficerForm 4 sale60,000$9.8M100.0%UnusualSEC